Drug recall · May 7, 2014
Fluoxetine Capsules recall
Why: Chemical Contamination: The recalling firm received notice that their supplier is recalling capsules due to complaints of capsules having an unusual odor.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Fluoxetine Capsules, USP, 20 mg, 30-count bottles, Rx only, Distributed by: Wal-Mart, Bentonville, AR 72716; Manufactured by: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960; Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045, NDC 68645-130-54, UPC 3 68645 13054 5.
- Lots / codes
Lot numbers: 131328, Exp 08/15; 131634, Exp 09/15; and 131833, Exp 11/15
- Quantity
- 667,068 bottles
- Company
- Legacy Pharmaceutical Packaging, Earth City, MO
- Distribution
- Nationwide
- Initiated
- February 14, 2014 · Voluntary: Firm initiated
- Classified
- April 28, 2014
- Reported
- May 7, 2014
- Ended
- November 27, 2017
- How notified
- Telephone
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fluoxetine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.